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The cytokine interleukin 1 (IL 1) plays an important role in the induction of IL 2 
secretion and high-affinity IL 2 receptor (IL 2R) expression by T cells. The events 
that follow binding of IL 1 to IL lR, however, are still unknown. In this study we 
describe two variants of the murine thymoma EL4 (5D3 and D6/76) that express 
comparable numbers of cell surface IL 1 receptors and bind IL 1 with the same 
affinity, but show distinct IL 1-dependent IL 2 secretion and IL 2R expression. In the 
presence of the tumor promoter phorbol 12-myristate 13-acetate IL 1 augments IL 2 
secretion and IL 2R expression of EL4 5D3 but not of EL4 D6/76 cells. Comparison 
of the internalization of IL 1 by both clones revealed that EL4 D6/76 was unable to 
transport cell surface-bound IL 1 to the cytoplasm. These findings suggest that inter- 
nalization of receptor-bound IL 1 is required for the action of this cytokine. 
1 Introduction 
Secretion of interleukin 2 (IL 2) and expression of high-affin- 
ity receptors for IL 2 (IL 2R) are required for proliferation of 
T lymphocytes upon antigen or mitogen stimulation. The 
cytokine IL 1 plays a key role in the induction of these pro- 
cesses. It has been demonstrated that IL 1 induces IL 2 secre- 
tion by normal and neoplastic T helper cells upon mitogen 
stimulation [ l ,  21. In addition, IL 1 induces IL 2R expression 
on a cloned antigen-specific helper T cell line in the presence 
of a monoclonal antibody (mAb) specific for the antigen 
receptor [3] and on murine thymocytes in the presence of IL 2 
[4]. Williams et al. could demonstrate that human peripheral 
blood T cells secrete IL 2 and express IL 2R induced by IL 1 
and mAb to the antigen receptor complex [5].  Furthermore, 
Lowenthal et al. [6] showed that IL 1 can augment both IL 2 
secretion and IL 2R expression of the murine thymoma EL4 
6.1 in the presence of the tumor promoter phorbol 12-myris- 
tate 13-acetate (PMA). 
Many cells respond to growth factors by internalization of the 
receptor ligand complex [7]. This observation has also been 
made for IL 1. IL 1 is rapidly internalized, presumably as a 
receptor ligand complex, and transported to the nucleus in 
ELA cells and Swiss 3T3 fibroblasts [8]. Whether internaliza- 
tion is required for a response to IL 1 leading to secretion of 
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of IL 2 and IL 2R expression in not known. In this study we 
investigated this question and we describe a variant of the 
murine thymoma EL4 that has lost the capacity to internalize 
cell surface receptor bound IL 1. This variant did not react to 
IL 1 with enhanced IL 2 secretion and IL 2R expression in the 
presence of PMA. Therefore, the data presented here suggest 
that internalization of IL 1 is a prerequisite for the IL 1- 
dependent increase of PMA-induced IL 2 secretion and IL 2R 
expression of EL4 thymoma cells. Thus, the EL4 variants 
described in this study could serve as a model for investigation 
of the initial biochemical processes that follow IL 1 stimula- 
tion of T cells. 
2 Materials and methods 
2.1 Cell cultures and reagents 
Cells were cultured in RPMI 1640 containing 5% fetal calf 
serum (FCS) and 50 pglml gentamycin at 37 "C in a humidified 
atmosphere of 5% COz in air. PMA was purchased from 
Sigma Chemical Co. (St. Louis, MO). Disuccinimidyl suberate 
(DSS) was obtained from Pierce Chemical Co. (Rockville, 
IL) . 
2.2 IL 1 
Human recombinant (hu r) IL la was kindly provided by Drs. 
A. Stem and P. Lomedico (Hoffmann-LaRoche, Nutley, NJ). 
The specific activity was 5 x 106 U/mg protein determined by 
the lymphocyte-activating factor assay. 
2.3 Cloning of EL4 cells 
Cells were cloned under limiting dilution conditions. EL4 5D3 
was selected for high PMA-induced IL 2 secretion. ELA D6/76 
was selected for low incorporation of '*'I-labeled hu rIL la at 
37 "C. 
2.4 Assay for IL 2 
IL 2 activity in supernatants (SN) was quantitated by the abil- 
ity of the SN to support growth of the IL 2-dependent murine 
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T cell clone W2 as described elsewhere [9]. Units of IL 2 are 
based on a standard purchased from Biogen (Geneva, Switzer- 
land; Batch No. RNB85738/09Y). IL 2 secretion was induced 
with 5 x 16 celldm1 in culture medium (2-ml cultures) with the 
addition of hu rIL la (10 U/ml) and PMA (see Table 1) for 
32 h. SN were removed for IL 2 determination. 
2.5 Assay for IL 2R expression 
Affinity-purified mAb 7D4 [ 101 was radioiodinated using the 
chloramine-T method [ll]. Cells induced either with IL 1 and 
PMA or PMA alone for 30 h were washed and resuspended in 
90 p1 binding medium (RPMI 1640, 0 . 0 0 6 ~  Hepes, 1% 
bovine serum albumin, 0.1% sodium azide). mAb 7D4 was 
added in 10 pl binding medium to a final concentration of 4 pg/ 
ml. After incubation of ice for 1 h unbound radioactivity was 
removed by extensive washing with phosphate-buffered saline 
(PBS). The cells were lysed in 200 p1 PBS containing 0.1% 
sodium dodecyl sulfate (SDS). Aliquots of 180 p1 were 
removed and radioactivity was determined in a gamma 
counter. 
2.6 RNA extraction and hybridization procedures 
Cytoplasmic RNA was prepared by the method of Cheley and 
Anderson [12]. Cells (1 x lo6 - 2 x lo6) were lysed with 1 ml 
7.6 M guanidinium hydrochloride (Fluka, Neu-Ulm, FRG) in 
0.1 M potassium acetate, pH 5. DNA was sheared by aspira- 
tion (6 X)  through a 21 gauge needle. RNA was precipitated 
over night at - 20 "C after addition of 0.6 ml of ethanol. After 
centrifugation the pellet was dissolved in 200 pl of 15% form- 
aldehyde in water. To this solution 200 p1 of 20 x SSC was 
added and RNA was denatured by heating to 50 "C for 15 min. 
Aliquots were applicated onto nylon membranes in serial 3- 
fold dilutions (Compas, Genofit, Heidelberg, FRG). RNA 
was fixed on the membranes by UV irradiation for 2 min. The 
first well of the RNA dot blots represents cytoplasmic RNA 
equivalent to 5 x 16 cells. RNA for Northern analysis was 
prepared by the guanidine isothiocyanate/cesium chloride 
method. RNA was denatured with formaldehyde and elec- 
trophoresed in a 1% agarose gel. The blotting was done on 
nylon membranes (Compas). RNA was fixed by UV irradia- 
tion. Hybridizations were done according to the manufactur- 
er's protocol in the presence of dextran sulfate and formamide 
at 42 "C. The filters were washed twice under high stringency 
conditions (65 "C, 30 min, 2 x SSC containing 1% SDS). The 
probe for the mouse IL 2 was generously provided by Dr. A. 
Schimpl (Wiirzburg, FRG) and contains the complete exon 4 
of the IL 2 gene [13]. The probe for the mouse IL 2R was 
generously provided by Dr. T. Malek (Miami, FL). It repre- 
sents the Eco RI-Pst I fragment of the IL 2R cDNA (clone 
pmIL 2prl) [14]. Probes were labeled overnight with "P-GTP 
and 32P-CTP (spec. act. 3000 Ci/mmol = 111 TBq/mmol; 
Amersham, Frankfurt, FRG) by the random primer method 
using a hexamer (Pharmacia Fine Chemicals, Uppsala, Swe- 
den) as primer. 
2.7 Iodination of hu rIL la 
Purified hu rIL la was labeled with '"I by utilizing the Enzy- 
mobead reagent according to the manufacturer's instructions 
(Bio-Rad, Richmond, CA). The 'zI-labeled rIL la was sepa- 
rated from unbound Na12'I by chromatography on a Sephadex 
G-25 column (PD10; Pharmacia) which was equilibrated with 
RPMI 1640 containing 5% FCS prior to use. Biological activity 
of the iodinated material was 80% to 90% of the original 
material (data not shown). IL 1 activity of this material was 
determined using the standard phytohemagglutinin (PHA)- 
costimulator assay with MTT as described [15]. 
2.8 Binding of %rIL l a  
Cells (2 x lo6) were incubated with various concentrations of 
'*'I-rIL la in 200 p1 binding medium (RPMI 1640, 0.006 M 
Hepes, 1% BSA, 0.1 Sodium azide) at 8 "C for 4 h. Two 95 p1 
aliquots were removed and centrifuged through a mixture of 
dibutylphthalate: phthalic acid bis(2-ethylhexylester) (1.5 : 1). 
The assay was done in duplicate. Radioactivity of the cell pel- 
let and the SN was determined in a gamma counter. Non- 
specific binding was measured in the presence of a 100-fold 
excess of unlabeled rIL l a .  Scatchard plots [16] of equilibrium 
data were analyzed by using a computer program (Dr. L. 
Erkell, German Cancer Research Center, Heidelberg, per- 
sonal communication). 
2.9 Affiiity cross-linking and SDS-polyacrylamide gel elec- 
trophoresis (PAGE) 
Cells were preincubated at 37 "C for 30 min in the presence of 
0.1% sodium-azide to inhibit internalization of receptor ligand 
complexes. Then 1 x lo7 cells were incubated for 2 h at room 
temperature with '"I-rIL la in 500 p1 binding medium in the 
presence or absence of unlabeled rIL l a .  Subsequently, the 
cells were washed twice by centrifugation with PBS, pH 8.4, 
and resuspended in 100 pl PBS, pH 8.4.4 pl DSS (50 mg/ml in 
dimethyl sulfoxide) was added to give a final concentration of 
2 mg/ml, and the mixture was incubated at room temperature 
for 1 h. The cells were then washed twice with PBS and lysed 
in 40 p1 buffer (PBS 1% Triton X-100,2 mM phenylmethylsul- 
fonyl fluoride) on ice for 5 min. Samples were centrifuged at 
10000 x g at 8 "C for 15 min to remove cell debris. The SN 
was mixed with 40 p12 X dissociation buffer (0.14 M Tris-HC1, 
pH 6.8; 4% SDS; 20% glycerol; 0.008% bromophenol blue). 
Samples were boiled for 3 min and subjected to 10% SDS- 
PAGE using the procedure of Laemmli [17]. 
2.10 Internalization of '%IL la 
To determine the kinetics of internalization of lZI-rIL la 
4 x lo6 cells and 8 U of lZI-rIL la were preincubated in 
500 pl RPMI 1640 containing 5% FCS at 8 "C for 1 h and then 
transferred to 37 "C. Samples were removed at the indicated 
times. Cells were pelleted by centrifugation and resuspended 
in 500 p1, pH 3, buffered medium. After incubation on ice for 
5 min to remove surface-bound radioactivity [18] cells were 
centrifuged again and lysed in 200 pl lysis buffer (10 mM Tris 
HCl, pH 7.4; 150 mM NaC1; 1% Triton X-114; 2 mM phenyl- 
methylsulfonyl fluoride; 2% isopropanol). After 10 min incu- 
bation on ice the nuclear and cytoplasmic fractions were sepa- 
rated by centrifugation at loo00 x g at 8 "C for 10 min. 
Radioactivity in both fractions was determined in a gamma 
counter. Purity of the nuclear preparation was controlled mic- 
roscopically after staining with M + D Diff Quick according to 
the manufacturer's instructions (Merz-Dade, AG, Diidingen, 
Switzerland). 
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3 Results 
3.1 IL 1-induced IL 2 secretion and IL 2R expression 
The tumor promoter PMA induces the murine thymoma EL4 
to secrete IL 2 and to express IL 2R. Both activities can be 
augmented by IL 1 in a dose-dependent manner [6]. To inves- 
tigate the mechanisms that lead to IL 1-induced IL 2 secretion 
and IL 2R expression, two EL4 subclones (5D3 and D6/76) 
were selected by cloning under limiting dilution conditions. 
These subclones differ in their capacity to respond to IL 1 in 
the presence of PMA. Table 1 shows that IL 1 augments the 
PMA-induced IL 2 secretion of EL4 5D3, and that the effect 
of IL 1 is more pronounced under suboptimal PMA concen- 
trations (2 ng/ml PMA). This is consistent with the data pub- 
lished by Lowenthal et al. [6]. In contrast, IL 2 secretion of 
EL4 D6/76 was not enhanced by addition of IL 1 to the cul- 
tures. IL l alone did not have any effect on either cell line 
(data not shown). 
We also tested whether EL4 5D3 and EL4 D6/76 showed a 
different response to IL 1 with respect to IL 2R expression. 
Cells were activated with IL 1 and PMA or PMA alone, and 
after 30 h of activation binding of laI-labeled mAb 7D4 was 
measured. mAb 7D4 specifically recognizes the p55 protein of 
the IL 2R complex [lo]. The results of these experiments are 
summarized in Table 2. The amount of radioactivity bound to 
PMA-stimulated EL4 5D3 cells was significantly enhanced by 
Table 1. Induction of IL 2 secretion by IL 1 and PMA 
Additions to cultureb) IL 2 secretion (U/ml)') 
by EL4 subclones 
EL45D3 EL4D6/76 
PMA (2 ng/ml) 5 6 
PMA (2 ng/ml) IL la (10 U/ml) 30 6 
PMA (20 ng/ml) IL la (10 U/ml) 100 30 
PMA (20 ng/ml) 75 30 
a) Units of IL 2 in the SN of the clones were based on the standard 
purchased from Biogen, Geneva, Switzerland (Batch No. 
RNB85738D9Y). 
b) Cell concentration 5 X ld/ml. Cells were incubated with IL 1 and 
PMA for 32 h. 
Table 2. Induction of IL 2R expression by IL 1 and PMA 
Additions to culture Binding of '%abeled 
mAb 7D4 to cells (cpm)" 
IL 1 PMA') EL4 5D3') EJA D6176') 
- - 232 282 
- + 12% 1922 
0.625 U/ml + 4885 2121 
10 + 7565 1819 
a) 'zI-labeled mAb 7D4 was added at a final concentration of 4 pg/ml 
to 1 x 1d cells. 
b) PMA was added to a final concentration of 10 ng/ml. 
c) IL 2R expression was measured after a 30-h activation of cells. 
IL 1 in a dose-dependent manner. On the contrary, in the 
presence of PMA IL 1 did not augment the binding of radioac- 
tive mAb 7D4 to EL4 D6/76 cells. The data presented in 
Tables 1 and 2 clearly demonstrate that both EL4 clones were 
capable of IL 2 secretion and IL 2R expression in the presence 
of PMA. Only clone EL4 5D3, however, and not clone EL4 
D6/76, was further stimulated by IL 1. 
3.2 Quantity of induced IL 2 and IL 2R mRNA in EL4 clones 
To investigate whether the IL 1-induced increase in IL 2 and 
IL 2R expression on EL4 5D3 was due to increased amounts 
of mRNA rather than to increased translation, we compared 
the induction of specific mRNA in EL4 5D3 and EL4 D6/76. 
Cells were induced with IL 1 and PMA or PMA alone for 24 
and 48 h, and cytoplasmic RNA extracts were probed for IL 2 
and IL 2R mRNA, respectively. The results of these experi- 
ments are shown in Fig. 1. After 24 h of induction EL4 5D3 
showed a significant amount of IL 2-specific mRNA induced 
by PMA (Fig. lA, lane 1). The amount of mRNA was further 
augmented by addition of IL 1 (Fig. lA, lane 2). In contrast, 
the amount of IL 2 mRNA synthesized by EL4 D6/76 could 
not be further augmented by IL 1 (Fig. lA, lanes 3 and 4, 
respectively). After 48 h of induction EL4 5D3 also expressed 
a significant amount of IL 2R mRNA (Fig. lB, lane 1). 
Again, in the presence of IL 1 a substantial increase of IL 2R 
mRNA was observed for EL4 5D3 (Fig. lB, lane 2) but not 
for EL4 D6/76 (Fig. lB, lanes 3 and 4, respectively). The IL 1- 
induced increase of IL 2 mRNA of clone EL4 5D3 as shown 
by dot blot analysis in Fig. 1A was also evident from the 
Northern blot in Fig. 1C. From these data it can be concluded, 
that the effect of IL 1 was most likely due to increased trans- 
cription of IL 2 and IL 2R genes. 
3.3 Number and affinity of IL 1R on EL4 5D3 and EL4 D6/76 
cells 
It has been shown previously that IL 1 binds to specific cell 
surface receptors [18, 191. The lack of response of EL4 D6/76 
to IL 1 could therefore be explained by the absence of cell 
surface IL 1R. To test this hypothesis, we determined receptor 
numbers and dissociation constants for IL 1 for both clones by 
Scatchard plot analysis [16]. We found that EL4 D6/76 and 
EL4 5D3 expressed 2300 to 2400 cells surface IL 1R per cell (? 
= 0.98 and 0.99, respectively) with an apparent dissociation 
constant in the range of 1.2 x lo-'' - 2.5 X lo-'' M. This 
dissociation constant is in good agreement with the data pub- 
lished for EL4 by Kilian et al. [19]. Thus, our data indicate 
that the two clones do not differ in IL 1R density of affinity. 
3.4 Affinity cross-lining of '%IL 1 to the cell receptors 
The Scatchard plot analysis ruled out that EL4 D6/76 was 
unreactive to IL 1 as a consequence of missing IL 1R. A dele- 
tion in the cytoplasmic tail of the receptor molecule, however, 
could account for the lack of IL 1-dependent signal transduc- 
tion in EL4 D6/76. Therefore, to detect any major differences 
of the receptor molecules on both clones, the size of the recep- 
tor ligand complex was determined by SDS-PAGE after affin- 
ity cross-linking of cell surface receptors to '251-rIL la .  EL4 
5D3 and EL4 D6/76 cells were incubated with 'aI-rIL la in the 
presence or absence of unlabeled IL 1 followed by addition of 
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(A) (B) (C) 
Figure 1. Quantity of IL 1-induced IL 2 and IL 2R mRNA in EL4 
clones. (A) Activation of EL4 5D3 (lanes 1 and 2) and EL4 D6/76 
(lanes 3 and 4) with 5 ng/ml PMA (lanes 1 and 3) or 5 ng/d  PMA and 
5 U/ml rIL la (lanes 2 and 4) for 24 h. Dot blot with the IL 2 probe. 
(B) Activation of EL4 5D3 (lanes 1 and 2) and EL4 D6/76 (lanes 3 and 
4) with 20 ng/ml PMA (lanes 1 and 3) or 20 n g h l  PMA and 5 U/ml 
rIL la (lanes 2 and 4) for 48 h. Dot blot with the IL 2R probe. Cyto- 
plasmic RNA from the macrophage cell line PU5-1.8 did not 
hybridize with the IL 2 and IL 2R probes. (C) Northern analysis of 
EL4 5D3 RNA after stimulation with PMA (5 ng/ml, lane 1) or PMA 
and hu rIL la (10 U / d ,  lane 2) for 8 h. The IL 2 probe was used. No 
hybridization using the IL 2 or IL 2R probe was obtained with RNA 
from unstimulated EL4 cells. 
the bivalent lysine directed crosslinker DSS. Detergent 
extracts were analyzed under nonreducing conditions on SDS- 
PAGE as shown in Fig. 2. Cross-linking of lZI-rIL la to EL4 
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Figure 2. Characterization of IL 1R on EL4 5D3 and EL4 D6/76 by 
affinity cross-linking with '%IL la. IzI-rIL la was cross-linked to 
cells by the lysine-directed reagent DSS. Detergent lysates of cells 
were analyzed by 10% SDS-PAGE under nonreducing conditions. 
Lanes 1, 2, 3 EL4 D6/76; lanes 4, 5 ,  6 EL4 5D3; Negative controls 
contain an excess of unlabeled rIL la (lanes 2 and 5 )  or the cross- 
linker was omitted (lanes 3 and 6). The mol. wt ( x lo-') is indicated in 
the right margin. 
in a radioactive band with a molecular size of approximately 
100 kDa revealing a mol. mass of 80-85 kDa for the receptor 
molecule. This mol. mass is consistent with the data published 
by Bron and MacDonald [20] for EL4 6.1 and by Dower et al. 
for LBRM-33-1A5 [21]. In the presence of cold rIL la the 
radioactive band was either drastically reduced for EL4 D6176 
(Fig. 2, lane 2) or completely absent for EL4 5D3 (Fig. 2, lane 
5) .  In the absence of the crosslinker no bands could be 
observed (Fig. 2, lanes 3 and 6). These data show that the mol. 
wt. of the IL 1R of the two clones are identical. However, 
small deletions or amino acid substitutions in the receptor 
molecule expressed by EL4 D6/76 would not be detected by 
this method. 
3.5 Internalization of '%rIL la 
Mzel et al. [8] have shown that labeled IL 1 is transported to 
the nucleus in EL4 and Swiss 3T3 cells. To test the possibility 
that EL4 D6/76 might have lost the capacity to internalize the 
IL 1R complex, we monitored the uptake of lBI rIL la by 
these cells over a time period of 6 h. Fig. 3 shows a representa- 
tive experiment out of five. Cells were incubated at 37 "C with 
'*'I rIL l a .  At the indicated times cell surface-bound radioac- 
tivity was removed by pH 3 treatment, cells were lysed and the 
lysate was separated into cytoplasmic and nuclear fractions as 
described in Sect. 2. Radioactivity accumulated in the cysto- 
plasmic fraction of EL4 5D3 cells and reached a plateau after 3 
to 4 h. In contrast, there was no significant increase of radioac- 
tivity in the corresponding cytoplasmic fraction of EL4 D6/76. 
The same picture arose when the amount of radioactivity in 
the nuclear fractions of the two clones was compared (Fig. 3). 
The same experiment was carried out in the presence of Ph4A 
and showed no qualitative difference to the experiment 
described in Fig. 3. EL4 D6/76 did not internalize IL 1 
7 
0' 
0 1 2 3 4  5 6  
Time (h) 
Figure 3. Internalization of %IL la. After preincubation of EL4 
5D3 or EL4 D6/76 cells with IZSI-rIL la at 8 "C for 1 h samples were 
transferred to 37 "C. Aliquots were taken at the indicated times and 
the amount of radioactivity in the nuclear and cytoplasmic fractions 
was determined. EL4 5D3 nuclear (M) and cytoplasmic fraction 
(-0); EL4 D6/76 nuclear ( ) and cytoplasmic fraction 
(C-W 
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whereas EL4 5D3 only showed an insignificant increase of 
IL 1 internalization (about 20%). 
Although EL4 D6/76 expressed the same amount of cell sur- 
face receptors and bound IL 1 with the same affinity as EL4 
5D3, '251-IL la bound to the cell surface of EL4 D6/76 was not 
transported into the cell. We do not know why nuclear binding 
of IL 1 precedes cytoplasmic accumulation. One could specu- 
late, however, that transport of IL 1 and binding to a putative 
nuclear IL 1R is fast and accumulation of IL 1 in the cyto- 
plasm is only seen when nuclear binding reaches saturation. 
We concluded from our data that the inability of EL4 D6/76 to 
respond to IL 1 with increased IL 2 secretion and IL 2R 
expression is a consequence of a defect of this cell line to 
internalize IL 1. 
4 Discussion 
The events that follow binding of IL 1 to the specific cell sur- 
face receptors and lead to secretion of IL 2 and expression of 
IL 2R during T cell activation are still largely unknown. In this 
study we describe two variants of the murine thymoma EL4, 
EL4 5D3 and EL4 D6/76, which may help us to understand the 
initial processes of the cellular response to IL 1. The cell sur- 
face receptors for IL 1 expressed by these two subclones show 
no significant differences in number, affinity for IL 1 or 
molecular size (Fig. 2). However, in the presence of PMA 
only EL4 5D3, but not EL4 D6/76, responded to IL 1 with 
increased IL 2 secretion (Table 1) and IL 2R expression 
(Table 2). This response was correlated with increased 
amounts of IL 1-induced IL 2 and IL 2R mRNA (Fig. 1). The 
most significant result of our experiments was that the 
response of the EL4 clones correlated with the internalization 
of the receptor-bound '251-rIL la. The EL4 clone EL4 D6/76, 
which did not respond to IL 1 also did not internalize lZ5I- 
rIL la (Fig. 3). Whether internalization of IL 1 or its trans- 
port to the nucleus as demonstrated in this report and in a 
previous one by Mizel et al. [8] are necessary for a response of 
a cell to IL 1 is not known. Our data, however, support this 
hypothesis and show that binding of IL 1 to the IL 1R is not 
sufficient to trigger a biological response. Further support for 
the importance of IL 1 internalization for IL 1 action comes 
from our experiments that chloroquine (10 yg/ml) inhibited 
IL 1-induced IL 2 secretion of EL4 5D3 cells (5 X l@/ml) by 
40 to 70%. Thus, it might be possible that a response to IL 1 
can only be achieved when it reacts with a nuclear receptor as 
postulated by Mizel et al. [8]. 
We have considered the possibility that the defect in internali- 
zation of IL 1 by EL4 D6/76 might be due to a defect in the 
IL 1R molecule. Such defects have indeed been described for 
the human low density lipoprotein (LDL) receptor. LDL 
receptors that missed the cytoplasmic tail or differed in a single 
amino acid from the wild type sequence were nonfunctional 
(for review see [22]). Our experiments would not detect such 
minor differences in the IL 1R of the two clones. However, we 
have compared the receptor proteins expressed by EL4 5D3 
and EL4 D6/76 on SDS-PAGE after cross-linking to labeled 
rIL la and found them to be identical in mol. wt. Thus, major 
differences of the receptor molecule could not be responsible 
for the internalization defect of EL4 D6/76. 
On the basis of no major differences in mol. wt. of the IL 1R 
molecules expressed by the two subclones we considered dif- 
ferences in biochemical events that follow binding of IL 1 to 
the receptor. First, we considered that the activity of protein 
kinase C was different in the two clones. This explanation was 
made unlikely by our finding that PMA alone stimulated IL 2 
secretion and IL 2R expression in both clones at about equal 
quantities. Our experiments do not rule out, however, that 
IL 1 may augment the activity of this enzyme as postulated 
previously [23]. The activity of protein b a s e  C is associated 
with the transport of this enzyme from the cytosol to the 
plasma membrane [24]. Abraham et al. showed, however, that 
IL 1 does not induce this process [25]. Thus, a difference in the 
biology of protein kinase C in these two clones is unlikely. 
Second, we considered a difference in a Ca2+-dependent acti- 
vation pathway. This was equally unlikely, since both clones 
showed an identical synergistic response to PMA and the Ca2+ 
ionophore ionomycin with respect to the secretion of IL 2 
(I. von Hoegen unpublished). 
Taken together, our data suggest that internalization of IL 1 is 
a prerequisite for the action of this cytokine. Since we have 
found no major differences in the number, affinity and mol. 
wt. of IL 1R and in the activity of protein kinase C or a Ca2+- 
dependent activation pathway of the two clones, a further 
biochemical characterization of the processes that follow IL 1 
stimulation will be needed to explain the internalization 
defect. The investigation of such processes may also lead to a 
better understanding of IL 1-dependent pathways of activa- 
tion of normal T cells. 
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